Thomas E. Sepe MD FACG, FAASLD, FAGA

Advanced Endoscopic Interventional, Hepatology & Liver Transplantation

University Gastroenterology

33 Staniford StProvidence, RI 02905
Phone+1 401-421-8800
Fax+1 401-273-6510

Dr. Sepe is on Doximity

As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Sepe's full profile Already have an account?

Summary

Thomas Sepe, MD, is a gastroenterologist based in Providence, RI, with subspecialties in Advanced Endoscopic Interventional and Hepatology & Liver Transplantation. He was trained in Internal Medicine at Beth Israel Deaconess Medical Center and later in Gastroenterology at Tufts Medical Center. Dr. Sepe has significant experience in various areas of his specialty, notably in general gastroenterology, hepatology, transplant hepatology, interventional gastroenterology, and biliary tract disease. He is an established author with works featured in the ACG Case Reports Journal and Hepatology Communications, among others. He has also conducted clinical trials related to Nonalcoholic Steatohepatitis (NASH). Dr. Sepe is recognized by professional associations including AASLD, Centers for Medicare & Medicaid Services, and the American Gastroenterological Association, among others.

Education & Training

Tufts Medical CenterFellowship, Gastroenterology, 1991 - 1993
Beth Israel Deaconess Medical CenterResidency, Internal Medicine, 1988 - 1991
Icahn School of Medicine at Mount SinaiClass of 1988

The following disclaimer is related to board certifications obtained from ABMS®, denoted by the ABMS® logo.

This information is proprietary data maintained in a copyrighted database owned by the American Board of Medical Specialties®. The display and presence of ABMS Data in no way constitutes any affiliation, association with, or endorsement of any advertising, promotion, or sponsorship by ABMS and its affiliates and subsidiaries, the ABMS Member Boards, or ABMS board certified physicians and medical specialists. Copyright 2026 American Board of Medical Specialties®. All rights reserved.

The user is responsible for ensuring that the profile obtained in this directory is the profile of the physician or medical specialist being sought.

A self-designated specialty, subspecialty, or practice area neither implies nor is equivalent to ABMS board certification or the existence of specialized training by or competence of a physician or medical specialist.

Certifications & Licensure

RI State Medical License 1993 - 2028
American Board of Internal Medicine Gastroenterology

Awards, Honors, & Recognition

CMS Meaningful Use Stage 2 Certification gGastro, gMed, Inc., 2012, 2014-2017
CMS Meaningful Use Stage 1 Certification gGastro, gMed, Inc., 2012, 2014-2017
Fellow AASLD, 2007

Clinical Trials

Clinical Trial to Evaluation the Safety and Efficacy of GR-MD-02 for the Treatment of Liver Fibrosis and Resultant Portal Hypertension in Patients With Nash Cirrhosis
COMPLETED
PHASE2
Randomized Global Phase 3 Study to Evaluate the Impact on NASH With Fibrosis of Obeticholic Acid Treatment Start of enrollment: 2015 Sep 22
TERMINATED
PHASE3
Study of TVB-2640 in Subjects With Nonalcoholic Steatohepatitis (NASH) Start of enrollment: 2021 Aug 12
COMPLETED
PHASE2
Roles: Contact

Publications & Presentations

PubMed

1 citations
Gastrointestinal Stromal Tumor Complicated by Fistula Formation.
Naveena Sunkara, Tyler Selig, Yousef Elfanagely, Thomas E Sepe
ACG Case Reports Journal. 2023-11-01
4 citations
Advancing research, awareness, screening, and linkage to care to eliminate HDV in the U.S.
Megan Glynn, Chari Cohen, Robert G Gish, Richard Andrews, Amy Trang
Hepatology Communications. 2023-07-01
4 citations
Ombitasvir/paritaprevir/ritonavir and dasabuvir with or without sofosbuvir for patients with hepatitis C virus genotype 1 infection who failed a prior course of direct...
Fred Poordad, Michael B. Bennett, Thomas Sepe, Eric Cohen, Robert Reindollar
Journal of Medical Virology. 2019-07-01

Press Mentions

Drs. Jeffrey Nadelson, Jonathan Hlivko & More: 4 GI Physicians Making HeadlinesJuly 27th, 2018
Najarian Named Medical Director of University Gastroenterology’s Pathology CenterJune 17th, 2018